Actively Recruiting
Analysis and Evaluation of Smoking Treatment With Cytisine
Led by Regina Elena Cancer Institute · Updated on 2024-06-03
65
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The lack of clinical studies on the use of Cytisine in the treatment of the cessation of smoking, the need to find effective therapeutic alternatives and the opportunity to reduce costs related to the complications of cigarette smoking, represent the main reasons that led to the design of this study.
CONDITIONS
Official Title
Analysis and Evaluation of Smoking Treatment With Cytisine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged over 18 years
- Patients with moderate or severe tobacco use disorder
- Patients prescribed pharmacological therapy with Cytisine
- Patients who returned for the first scheduled check-up visit
You will not qualify if you...
- Patients with contraindications to Cytisine and partial receptor agonists nicotinic cholinergics
- Patients undergoing pharmacological or physical treatment for cancer
- Pregnant or breastfeeding women
- Patients lacking specific information for objective assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
"Regina Elena" National Cancer Institute
Rome, Italy, 00144
Actively Recruiting
Research Team
M
Maria Papale, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here